ventures
AI driven personalized bioelectric stimulation
2019
Actively nurturing innovations as an idea pipeline for the Octane Group of Companies
Once an innovation is ready for spin-off, Octane Innovation explores the best commercialization strategy — whether that means a transfer to an existing company within the Octane Group of Companies, to a new Octane venture, or to a third-party partner.
At present, Octane Innovation is studying the untapped potential of AI powered bioelectric stimulation within the context of regenerative medicine.
We invite you to contact Octane Innovation to learn more about these and other discovery initiatives, or to explore partnership opportunities by way of confidential disclosures.